Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-8 of 8
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
20-Jun-2018Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME studyAnzueto, AR; Kostikas, K; Mezzi, K; Shen, S; Larbig, M, et al
15-May-2016Indacaterol/Glycopyrronium or Salmeterol/Fluticasone for COPD ExacerbationsWedzicha, JA; Banerji, D; Chapman, KR; Vestbo, J; Roche, N, et al
1-May-2017Blood Eosinophils and response to maintenance COPD treatment: data from the FLAME trialRoche, N; Chapman, KR; Vogelmeier, CF; Herth, FJ; Thach, C, et al
10-Apr-2018Exacerbation heterogeneity in COPD: subgroup analyses from the FLAME studyVogelmeier, CF; Chapman, KR; Miravitlles, M; Roche, N; Vestbo, J, et al
19-Jan-2017Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME studyWedzicha, JA; Zhong, N; Ichinose, M; Humphries, M; Fogel, R, et al
1-Nov-2017What Should Be the Cutoff Value of Blood Eosinophilia as a Predictor of Inhaled ReplyRoche, N; Chapman, KR; Vogelmeier, CF; Herth, FJF; Thach, C, et al
1-Aug-2018Long-term triple therapy de-escalation to indacaterol/glycopyrronium in COPD patients (SUNSET): a randomized, double-blind, triple-dummy clinical trialChapman, KR; Hurst, JR; Frent, S; Larbig, M; Fogel, R, et al
1-Jan-2019Capturing exacerbations of chronic obstructive pulmonary disease with EXACT: A sub-analysis of FLAMEFrent, SM; Chapman, KR; Larbig, M; Mackay, A; Fogel, R, et al